Malaysian Genomics Resource Centre Berhad (KLSE:MGRC)

KLSE:MGRC Cash Flow Statement

Financials in millions MYR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Net Income	-4.19	-14.34	-14.25	7.21	-4.29
Depreciation & Amortization	1.57	1.73	1.74	1.14	0.58
Loss (Gain) From Sale of Assets	-0.03	0	-	-	-
Asset Writedown & Restructuring Costs	-	0	0.01	0.14	0
Loss (Gain) From Sale of Investments	-	-	-	0	-
Provision & Write-off of Bad Debts	-1.44	5.03	7.54	0.47	-0.06
Other Operating Activities	-0.46	3.72	0.53	-1.28	-0.1
Change in Accounts Receivable	2.74	-12.75	-17.68	-5.59	-0.93
Change in Inventory	-0.32	-0.2	-0.11	-0.08	-0.22
Change in Accounts Payable	1.39	0.17	0.16	-1.96	2.38
Operating Cash Flow	-0.74	-16.64	-22.07	0.06	-2.64
Capital Expenditures	-0.2	-0.4	-0.44	-1.33	-3.96
Sale of Property, Plant & Equipment	0.03	0	0	-	-
Cash Acquisitions	-	-	-	-1.36	-
Sale (Purchase) of Intangibles	-0.01	-0	-0	-	-
Other Investing Activities	0	0.04	0.06	0.25	0.08
Investing Cash Flow	-0.18	-0.35	-0.38	-2.44	-3.89
Long-Term Debt Repaid	-0.23	-	-0.37	-0.32	-0.21
Total Debt Repaid	-0.23	-0.28	-0.37	-0.32	-0.21
Net Debt Issued (Repaid)	-0.23	-0.28	-0.37	-0.32	-0.21
Issuance of Common Stock	-	4.54	3.99	11.91	11.96
Financing Cash Flow	-0.23	4.27	3.62	11.59	11.75
Net Cash Flow	-1.15	-12.73	-18.83	9.21	5.23
Free Cash Flow	-0.95	-17.04	-22.51	-1.27	-6.6
Free Cash Flow Margin	-17.12%	-177.98%	-269.11%	-4.49%	-370.00%
Free Cash Flow Per Share	-0.01	-0.11	-0.18	-0.01	-0.06
Cash Interest Paid	0.11	0.09	0.1	0.1	0.09
Cash Income Tax Paid	0.15	0.1	0.12	-0	0.02
Levered Free Cash Flow	0.1	-	-17.33	-3.46	-5
Unlevered Free Cash Flow	0.17	-	-17.27	-3.4	-4.94
Change in Net Working Capital	-1.74	-	10.09	6.97	-1.15

Source: S&P Global Market Intelligence. Standard template. Financial Sources.